NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients

NanoZymeX develops lipid nanoparticle–based enzyme replacement therapy for Pompe disease. By improving efficacy and eliminating immunological side effects, we aim to extend the life expectancy and improve the quality of life of Pompe disease patients.